Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2015.255 | A PHASE III, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE EFFICACY AND SAFETY OF ATEZOLIZUMAB (MPDL3280A, ANTI−PD-L1 ANTIBODY) IN COMBINATION WITH CARBOPLATIN+NAB-PACLITAXEL FOR CHEMOTHERAPY-NAIVE PATIENTS WITH STAGE IV NON-SQUAMOUS NON−SMALL CELL LUNG CANCER | Prof. MOK Tony Shu Kam |
| 2015.607 | An Open-label Randomized Multinational Phase 3 Trial of Nivolumab versus Docetaxel in Previously Treated Subjects with Advanced or Metastatic Non-small Cell Lung Cancer |
Prof. MOK Tony Shu Kam 莫樹錦 |
| 2016.291 | A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF CARBOPLATIN PLUS ETOPOSIDE WITH OR WITHOUT ATEZOLIZUMAB (ANTI-PD-L1 ANTIBODY) IN PATIENTS WITH UNTREATED EXTENSIVE-STAGE SMALL CELL LUNG CANCER |
Prof. MOK Tony Shu Kam 莫樹錦 |
| 2026.422 | Solid tumor Study for Long term Treatment of Cancer Patients Who Have Participated in BMS-Parent Studies Investigating Adagrasib (BMS-986503) | Prof. MOK Tony Shu Kam |
| 2026.231 | A PHASE 2 INTERVENTIONAL STUDY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY IN PARTICIPANTS WITH PREVIOUSLY UNTREATED TRANSFORMED SMALL CELL LUNG CANCER | Prof. MOK Tony Shu Kam |
| 2026.319 | AN INTERVENTIONAL, OPEN-LABEL, PHASE 2 STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF PF-08634404 MONOTHERAPY OR IN COMBINATION IN ADULT PARTICIPANTS WITH EARLY-STAGE RESECTABLE OR LOCALLY ADVANCED UNRESECTABLE NON-SMALL CELL LUNG CANCER | Prof. MOK Tony Shu Kam |
| 2024.593 | A Phase Ib/II Dose Finding Study Assessing Safety and Efficacy of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Extensive Stage Small Cell Lung Cancer (ES-SCLC) in Combination with Carboplatin, Etoposide and Atezolizumab in Induction and with Atezolizumab in Maintenance Phase | Prof. MOK Tony Shu Kam |
| 2013.461 | A multicenter, open-label, randomized phase II study to evaluate the efficacy of AUY922 vs pemetrexed or docetaxel in NSCLC patients with EGFR mutations who have progressed on prior EGFR TKI treatment | Prof. MOK Tony Shu Kam |
| 2007.246 | A Double-Blind, Randomized, Placebo-Controlled Phase III Study to Assess the Efficacy of recMAGE-A3 + AS15 Antigen Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients with Resectable MAGE-A3-Positive Non-Small Cell Lung Cancer | Prof. MOK Tony SK |
| 2008.249 | Randomized, Open Label, Phase III Trial of CP-751, 871 in Combination with Paclitaxel and Carboplatin versus Paclitaxel and Carboplatin in Patients with Non-Small Cell Lung Cancer | Prof MOK Tony, S.K. |
| 2011.548 | A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) in Subjects With Mild to Moderate Alzheimer Disease Who Are Apolipoprotein E | Prof. MOK Vicent Chung Tong |
| 2013.660 | Evaluation of the need of CM services for stroke patients in Hong Kong | Prof. MOK Vincent |
| 2008.023 | Mechanisms for Cognitive Impairment in Chinese Patients with Confluent White Matter Lesion: Analysis of 99 Structural Brain Regions Using a Hybrid Volumetric and Surface Warping | Prof Mok Vincent |
| 2014.276 | Danshen and Gegen in improving Cerebral Haemodynamics in Cerebral White Matter Hyperintensities: A Pilot Study | Prof. MOK Vincent |
| 2024.225 | AlziAid: An AI-assisted Program for Diagnosing of Alzheimer’s Disease Using Iris & Pupil Movement |
Prof. MOK Vincent 莫仲棠 |
| 2020.536 | Enhancing Use of Telemedicine among Older People amid COVID-19 In Asia (EUTOPIA ) | Prof. MOK Vincent |
| 2023.348 | Brain Heath Service for Prevention of AD |
Prof. MOK Vincent 莫仲棠 |
| 2019.371 | Biomarkers in Neurodegenerative Diseases (NDD Registry) |
Prof. MOK Vincent 莫仲棠 |
| 2014.213 | Physiological basis of motor facilitation by visual cues in Parkinson's disease | Prof Mok Vincent |
| 2013.681 | A nested case-control study to investigate microRNA as a screening biomarker for asymptomatic elders with white matter hyperintensities at risk of incident dementia and stroke | Prof. Mok Vincent C T |
| 2012.167 | MicroRNA expression pattern in stroke patients: a pilot study | Prof Mok Vincent C.T |
| 2015.574 | Establishment of reference genome of Hong Kong population for biomarker identification in Alzheimer's disease |
Prof. MOK Vincent C.T. 莫仲棠 |
| 2015.449 | mPower - Mobile Parkinson’s Disease Study |
Dr. MOK Vincent C.T. 莫仲棠 |
| 2016.065 | Identifying Fluctuators in Parkinson's Disease with Objective Assessment Technology |
Prof. MOK Vincent C.T. 莫仲棠 |
| 2016.176 | A prospective cohort study: The use of iPhone ECG monitoring in acute ischemic stroke during hospitalization in Hong Kong |
Prof. MOK Vincent Chung Tong 莫仲棠 |
| 2017.337 | Impact of oculomotor deficits on dynamic visual functions in Parkinson's Disease |
Prof. MOK Vincent Chung Tong 莫仲棠 |
| 2017.576 | An alternative method to identify cerebral small vessel disease using retinal vascular imaging |
Prof. MOK Vincent Chung Tong 莫仲棠 |
| 2015.682 | A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF CRENEZUMAB IN PATIENTS WITH PRODROMAL TO MILD ALZHEIMER’S DISEASE |
Prof. MOK Vincent Chung Tong 莫仲棠 |
| 2014.023 | Hong Kong Registry of Early Onset Dementia | Prof. MOK Vincent Chung Tong |
| 2013.433 | Development of normative data for NINDS - Canadian Stroke Network Vascular Cognitive Impairment Neuropsychology Protocols | Prof. MOK Vincent Chung Tong |
| 2016.318 | Cerebral white matter hyperintensities, connectivity disruption and cortical thinning in elderly with small vessel disease |
Prof. MOK Vincent Chung Tong 莫仲棠 |
| 2014.227 | A multicenter, double-blind, placebo-controlled, randomised, paralle-group phase 3 study to evaluate the safety and efficacy of masitinib in patients with mild to moderate Alzheimer’s disease | Prof. MOK Vincent Chung Tong |
| 2017.109 | Plasma microRNA dysregulation for the identification of smal vessel disease |
Prof. MOK Vincent Chung Tong 莫仲棠 |
| 2016.666 | A Review Of Myotonic Dystrophy In Hong Kong |
Prof. MOK Vincent Chung Tong 莫仲棠 |
| 2017.254 | Identifying biomarkers in Alzheimer’s disease |
Prof. MOK Vincent Chung Tong 莫仲棠 |
| 2014.362 | A retrospective cross-sectional study of different types of Traditional Chinese Medicine for post-stroke rehabilitation in Hong Kong | Prof. MOK Vincent Chung Tong |
| 2016.404 | Hepcidin as Diagnostic Marker for PD and Other Neurodegenerative Diseases |
Prof. MOK Vincent Chung Tong 莫仲棠 |
| 2016.099 | Enhanced External Counterpulsation for Cerebral Confluent White Matter Hyperintensities |
Prof. MOK Vincent Chung Tong 莫仲棠 |
| 2014.360 | Burden, distress and quality of life and moderating effects of mental flexibility and personality traits in caregivers of patients with Frontotemporal Lobar Degeneration | Prof. MOK Vincent Chung Tong |
| 2011.238 | Comparative assessment of difference in reward processing of the brain among normal subjects, stroke patients and major depressive disorder patients | Prof. MOK Vincent Chung Tong |
| 2009.530 | Efficacy of Rivastigmine Transdermal Patch in Dementia Patients who do not benefit from Oral Acetylcholinesterase Inhibitors (AChIs) | Prof. Mok Vincent Chung Tong |
| 2009.434 | Pilot study of Enhanced External Conterpulsation Therapy for Diffuse Age-related White Matter Change | Prof. MOK Vincent Chung Tong |
| 2011.090 | Risk index for screening subclinical brian lesions in communitydwelling elderly persons in Hong Kong | Prof. MOK Vincent Chung Tong |
| 2009.497 | Follow-up of a randomized clinical trial ("ViNeuro"): Incidence of Cognitive decline and dementia in Chinese Parkinson's disease patients | Prof. Mok Vincent Chung Tong |
| 2013.025 | Cilostazol and Cerebral Haemodynamics in Cerebral Small Vessel Disease | Prof. Mok Vincent Chung Tong |
| 2009.118 | Pilot Study of Cognitive Registry at Acute Stroke Unit at Prince of Wales Hospital | Prof. Mok Vincent Chung Tong |
| 2009.495 | Early Identificaion of significant subclinical brain lesions in community-dwelling elderly persons in Hong Kong | Prof. Mok Vincent Chung Tong |
| 2010.540 | Transcranial Doppler Ultrasound for Detection of Cerebral White Matter Changes in High-Risk Population | Prof Mok Vincent Chung Tong |
| 2011.406 | Adaptation of the Booklet Category Test in Chinese: A pilot study | Prof MOK Vincent Chung Tong |
| 2009.032 | Neuroimaging Predictors for Cognitive Impairment in Chinese Patients with Confluent White Matter Lesion | Prof. Mok Vincent Chung Tong |
Page 185 of 289.